Form 8-K - Current report:
SEC Accession No. 0001564590-17-022482
Filing Date
2017-11-08
Accepted
2017-11-08 07:15:22
Documents
2
Period of Report
2017-11-08
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K clsd-8k_20171108.htm 8-K 26297
2 EX-99.1 clsd-ex991_6.htm EX-99.1 123901
  Complete submission text file 0001564590-17-022482.txt   151348
Mailing Address 900 NORTH POINT PARKWAY SUITE 200 ALPHARETTA 2Q 30005
Business Address 900 NORTH POINT PARKWAY SUITE 200 ALPHARETTA 2Q 30005 678-270-3631
Clearside Biomedical, Inc. (Filer) CIK: 0001539029 (see all company filings)

IRS No.: 452437375 | State of Incorp.: GA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37783 | Film No.: 171185056
SIC: 2834 Pharmaceutical Preparations